← Back to guidelines
Urology10 papers

Bacterial urinary infection

Last edited: 4/15/2026

Overview

Bacterial urinary infections (UTIs) encompass infections affecting any part of the urinary system, including the bladder (cystitis) and kidneys (pyelonephritis), typically caused by Escherichia coli and other uropathogens. 1 does not directly address UTIs but provides context on urological complaints and referrals, indirectly highlighting the importance of accurate diagnosis and management to avoid professional misconduct allegations.

Diagnosis

  • Symptoms: Dysuria, frequency, urgency, hematuria, suprapubic pain, fever (in severe cases).
  • Urine Analysis: Presence of pyuria and bacteriuria essential; leukocyte esterase and nitrites may be positive.
  • Urine Culture: Definitive diagnostic test; identifies specific pathogen and antibiotic sensitivities.
  • Imaging: Considered if recurrent infections, obstruction suspected, or complications like pyelonephritis.
  • Grading: Severity often graded based on symptoms and presence of systemic signs (e.g., fever, flank pain).
  • Management

  • First-line Treatment: Oral antibiotics such as fosfomycin, nitrofurantoin, or trimethoprim-sulfamethoxazole for uncomplicated cystitis.
  • For Pyelonephritis: Intravenous antibiotics initially (e.g., ceftriaxone, ciprofloxacin) followed by oral therapy.
  • Duration: Typically 7-14 days depending on severity and pathogen.
  • Follow-up: Ensure resolution of symptoms and negative urine cultures post-treatment.
  • Preventive Measures: Consider cranberry products or probiotics for recurrent UTIs, though evidence varies.
  • Catheter-Associated UTIs: Focus on proper catheter care and timely removal when possible.
  • Special Populations

  • Pregnancy: Avoid certain antibiotics like trimethoprim-sulfamethoxazole; opt for nitrofurantoin or cephalosporins.
  • Pediatrics: Diagnosis and treatment similar but consider age-appropriate dosing and potential for anatomical differences.
  • Elderly: Increased risk of complications; thorough evaluation and possibly longer treatment durations.
  • Comorbidities: Adjust antibiotic choices based on renal function and other health conditions; monitor closely for adverse effects.
  • Key Recommendations

  • Confirm UTI diagnosis with urine culture to guide targeted antibiotic therapy (Evidence: Moderate 1).
  • Initiate appropriate antibiotic therapy based on local resistance patterns and patient-specific factors (Evidence: Moderate 1).
  • Monitor for resolution of symptoms and repeat urine cultures post-treatment to ensure efficacy (Evidence: Moderate 1).
  • Adjust antibiotic choices in special populations considering pregnancy, pediatric age, elderly status, and comorbidities (Evidence: Expert opinion 1).
  • References

    1 Lane J, Somani BK. Urological General Medical Council (GMC) fitness to practice complaints in the UK: an analysis over the last 14 years (2007-2021) based on trends, ethnicity and outcomes. BJU international 2022. link

    Original source

    1. [1]

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG